News

Three Duke Surgery Faculty Members Receive Distinguished Professorships

Three faculty members from the Duke Department of Surgery have received distinguished professorships from Duke University. Distinguished professorships are awarded to the most distinguished faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.

Duke Surgery Ranks First Nationwide in NIH Funding

The Blue Ridge Institute for Medical Research has released its 2018 rankings of NIH funding for basic and clinical science departments, revealing that Duke Surgery ranks highest nationwide with more than $30 million in funding committed to research.

Dynamic Equilibrium: Finding Balance for the Surgeon–Scientist

With a buzzing phone and dinging inbox repeatedly begging for her attention, Dr. Georgia Beasley momentarily tunes out the chaos to discuss the journey that led to her current position at Duke. Here, she splits her time between treating melanoma patients in the clinic and researching novel treatments for the disease in the laboratory.

Duke Surgeons Perform State's First Transplant from HIV-Positive Donor

The Duke transplant team recently performed the first liver transplant in the state of North Carolina of an organ from an HIV-positive donor to an HIV-positive recipient, an operation that would not have been possible before the Hope Act was passed in 2013. Previously, organs from donors with HIV infection in the U.S. could not be used and were routinely discarded.

Duke Surgery Faculty Selected for 2018 Duke LEADER Program

Five faculty members from the Duke Department of Surgery have been selected to participate in the 2018 Duke Leadership Development for Researchers (LEADER) program sponsored by the Duke University School of Medicine Office of Faculty Development.

Duke Surgery’s participants include the following members:

Duke Receives $12 Million to Improve Long-Term Outcomes for Transplant Patients

National Institutes of Health grant will fund research to develop safer, more effective therapies for patients undergoing organ transplants.

Photo: Dr. Stuart Knechtle, director of the Duke Transplant Center and liver transplant specialist, and Dr. Ahmad Zaaroura, abdominal transplant fellow in surgery

Duke researchers will lead a $12 million, five-year study to test novel therapies that aim to eliminate or minimize the need for life-long immunosuppressive drugs following transplantation.